USHealthcare

Pro-Dex Inc (PDEX)

US · Healthcare · Medical Instruments & Supplies

$68.44+7.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$19.9M
Revenue YoY
+14.6%
Net profit
$3.9M
Profit YoY
+20.2%
EPS
$1.20
EPS estimate
$0.62
Net margin
19.7%

EPS came in at 1.20 against a street estimate of 0.62 — a beat of 93.5%.

Key statistics

Market cap
$187.0M
P/E
16.1
Forward P/E
21.1
P/B
4.14
Book value
$14.14
EPS (TTM)
$3.63
52-week high
$68.99
52-week low
$23.47
50-day MA
$61.33
200-day MA
$47.11
Beta
0.02

Analyst view

Analysts rate Pro-Dex Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $70.00.

Shareholding

Insiders
37.08%
Institutions
32.39%

Largest institutional holders

FundStake
BlackRock Inc4.78%
Vanguard Group Inc4.53%
Vanguard Capital Management, LLC3.49%
Punch & Associates Inv Mgmt Inc1.93%
Dimensional Fund Advisors, Inc.1.78%
Geode Capital Management, LLC1.51%
Northern Trust Corp1.46%
State Street Corp1.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Pro-Dex Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-08-05.